CRINETICS PHARMACEUTICALS INC. - COMMON STOCK
53.14
04-October-24 15:59:59
15 minutes delayed
Stocks
+0.37
+0.70%
Today's range
52.73 - 53.59
ISIN
N/A
Source
NASDAQ
-
13 Oct 2022 08:00:02 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 Oct 2022 16:57:25 By Nasdaq GlobeNewswire
-
Innovation Passport Granted for CRN04777 for the Treatment of Congenital Hyperinsulinism
06 Oct 2022 08:00:02 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Appoints Dana Pizzuti, M.D. as Chief Development Officer
03 Oct 2022 08:00:01 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12 Sep 2022 08:00:01 By Nasdaq GlobeNewswire
-
08 Sep 2022 08:00:01 By Nasdaq GlobeNewswire
-
06 Sep 2022 08:00:02 By Nasdaq GlobeNewswire
-
02 Sep 2022 08:00:00 By Nasdaq GlobeNewswire
-
12 Aug 2022 08:00:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 Aug 2022 16:44:12 By Nasdaq GlobeNewswire
-
04 Aug 2022 08:00:01 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12 Jul 2022 17:09:22 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 Jun 2022 16:30:47 By Nasdaq GlobeNewswire
-
Crinetics Presents Clinical and Research Results at ENDO 2022
08 Jun 2022 07:30:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in the JMP Securities Life Sciences Conference
07 Jun 2022 07:30:00 By Nasdaq GlobeNewswire
-
25 May 2022 07:00:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
12 May 2022 16:41:57 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 May 2022 16:18:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Closing of Underwritten Common Stock Offering
18 Apr 2022 16:01:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering
12 Apr 2022 23:52:43 By Nasdaq GlobeNewswire